Loracarbef Pregnancy and Breastfeeding Warnings
Brand names: Lorabid, Lorabid Pulvules
Loracarbef Pregnancy Warnings
Loracarbef has been assigned to pregnancy category B by the FDA. Animal studies failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Loracarbef should only be given during pregnancy when benefit outweighs risk.
Loracarbef Breastfeeding Warnings
There are no data on the excretion of loracarbef into human milk. Other cephalosporins are excreted into human milk in small amounts; however, adverse effects in the nursing infant are unlikely. Other beta-lactam antibiotics have been classified as compatible with breast-feeding by the American Academy of Pediatrics.
See also
References for pregnancy information
- Product Information. Lorabid (loracarbef). Lilly, Eli and Company. 2002;PROD.
References for breastfeeding information
- Product Information. Lorabid (loracarbef). Lilly, Eli and Company. 2002;PROD.
- Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. Baltimore, MD: Williams & Wilkins. 1998.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
